The Scientist

» science funding and disease/medicine

Most Recent

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

A protein called Coco rouses dormant breast cancer cells in the lung.

0 Comments

image: Can Worms Alleviate Autism?

Can Worms Alleviate Autism?

By | November 27, 2012

Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.

10 Comments

image: Architecture Reveals Genome’s Secrets

Architecture Reveals Genome’s Secrets

By | November 25, 2012

Three-dimensional genome maps are leading to a deeper understanding of how the genome’s form influences its function.

4 Comments

image: Nose Cells Help Paralyzed Dogs

Nose Cells Help Paralyzed Dogs

By | November 20, 2012

A transplant of cells from the lining of the nose helps dogs with spinal injuries walk again.

1 Comment

image: BP to Pay $350 Million to Science

BP to Pay $350 Million to Science

By | November 16, 2012

As part of a $4.5 billion settlement with the federal government over the catastrophic 2010 oil spill, BP will continue to fund research in the Gulf of Mexico.

0 Comments

image: A Root Cause of Parkinson’s

A Root Cause of Parkinson’s

By | November 15, 2012

Misfolded α-synuclein proteins promote the spread of Parkinson’s pathology in mouse brains.

1 Comment

image: European Research Spends on Errors

European Research Spends on Errors

By | November 14, 2012

An estimated 360 million Euros from the coffers of EU research funding was spent mistakenly; auditors blame overly complicated funding rules.

0 Comments

image: Next Generation: Ear-Powered Batteries

Next Generation: Ear-Powered Batteries

By | November 11, 2012

Researchers use the electric potential of a guinea pig’s inner ear to harvest enough energy to run a tiny sensor.

1 Comment

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Neurons Compete to Form Memories
  3. Classic Example of Symbiosis Revised
  4. The Genetic Components of Rare Diseases
RayBiotech